Lenka Radová

3.8k total citations
135 papers, 2.7k citations indexed

About

Lenka Radová is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lenka Radová has authored 135 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 49 papers in Cancer Research and 31 papers in Oncology. Recurrent topics in Lenka Radová's work include MicroRNA in disease regulation (32 papers), Cancer-related molecular mechanisms research (23 papers) and Circular RNAs in diseases (17 papers). Lenka Radová is often cited by papers focused on MicroRNA in disease regulation (32 papers), Cancer-related molecular mechanisms research (23 papers) and Circular RNAs in diseases (17 papers). Lenka Radová collaborates with scholars based in Czechia, Austria and United Kingdom. Lenka Radová's co-authors include Ondřej Slabý, Marek Svoboda, Rostislav Vyzula, Jana Nekvindová, Alexandr Poprach, Igor Kišš, Radek Lakomý, Robert Iliev, Pavel Fabián and Martina Rédová and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lenka Radová

127 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lenka Radová Czechia 30 1.7k 1.5k 441 373 270 135 2.7k
Rakesh Singal United States 24 2.4k 1.4× 503 0.3× 565 1.3× 519 1.4× 173 0.6× 50 3.3k
Yong Xu China 26 1.1k 0.6× 631 0.4× 461 1.0× 404 1.1× 161 0.6× 83 2.1k
Christos K. Kontos Greece 31 1.7k 1.0× 1.2k 0.8× 607 1.4× 202 0.5× 241 0.9× 122 2.7k
Sohye Kang United States 16 1.9k 1.1× 353 0.2× 695 1.6× 379 1.0× 300 1.1× 18 2.4k
Cátia Moutinho Spain 27 2.2k 1.2× 1.2k 0.8× 816 1.9× 291 0.8× 481 1.8× 35 3.0k
Adriana Aguilar‐Mahecha Canada 19 835 0.5× 637 0.4× 420 1.0× 169 0.5× 115 0.4× 43 1.7k
Carl E. Freter United States 20 1.0k 0.6× 465 0.3× 514 1.2× 224 0.6× 387 1.4× 52 2.2k
Catherine Lofton–Day United States 20 1.5k 0.9× 1.1k 0.7× 1.3k 3.0× 572 1.5× 1.0k 3.9× 32 3.6k
Carmen S. Tellez United States 29 2.1k 1.2× 762 0.5× 830 1.9× 400 1.1× 111 0.4× 50 3.1k
Jer-Yen Yang United States 17 2.7k 1.6× 932 0.6× 1.1k 2.4× 159 0.4× 259 1.0× 20 3.4k

Countries citing papers authored by Lenka Radová

Since Specialization
Citations

This map shows the geographic impact of Lenka Radová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka Radová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka Radová more than expected).

Fields of papers citing papers by Lenka Radová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenka Radová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka Radová. The network helps show where Lenka Radová may publish in the future.

Co-authorship network of co-authors of Lenka Radová

This figure shows the co-authorship network connecting the top 25 collaborators of Lenka Radová. A scholar is included among the top collaborators of Lenka Radová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenka Radová. Lenka Radová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vojtová, Lucy, et al.. (2024). In vitro culture of leukemic cells in collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel. PeerJ. 12. e18637–e18637. 1 indexed citations
3.
Štork, Martin, Viera Sandecká, Zdeněk Adam, et al.. (2024). Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab‐exposed relapsed/refractory multiple myeloma patients: A retrospective analysis. European Journal Of Haematology. 113(6). 810–816.
4.
5.
Ošlejšková, Hana, et al.. (2023). CCL2/MCP-1, interleukin-8, and fractalkine/CXC3CL1: Potential biomarkers of epileptogenesis and pharmacoresistance in childhood epilepsy. European Journal of Paediatric Neurology. 46. 48–54. 12 indexed citations
6.
Gregorová, Jana, Lenka Radová, Lenka Pospíšilová, et al.. (2022). Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International Journal of Molecular Sciences. 23(23). 14765–14765. 4 indexed citations
7.
Skalnı́ková, Magdalena, Kateřina Staňo Kozubík, Lenka Radová, et al.. (2022). A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome. International Journal of Molecular Sciences. 23(2). 885–885. 3 indexed citations
8.
Tomandlová, Marie, Robert Staffa, Tomáš Křivka, et al.. (2022). Kinetics of d-lactate and ischemia-modified albumin after abdominal aortic surgery and their ability to predict intestinal ischemia. Clinical Biochemistry. 112. 43–47. 3 indexed citations
9.
Souček, Přemysl, et al.. (2021). Nucleotides in both donor and acceptor splice sites are responsible for choice in NAGNAG tandem splice sites. Cellular and Molecular Life Sciences. 78(21-22). 6979–6993. 4 indexed citations
10.
Malčíková, Jitka, Šárka Pavlová, Lenka Radová, et al.. (2021). Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 138(25). 2670–2685. 24 indexed citations
11.
Gregorová, Jana, Lenka Radová, Martina Almáši, et al.. (2021). LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients. Biomedicines. 9(11). 1637–1637. 5 indexed citations
12.
Souček, Přemysl, Kamila Réblová, Lenka Radová, et al.. (2019). High-throughput analysis revealed mutations’ diverging effects on SMN1 exon 7 splicing. RNA Biology. 16(10). 1364–1376. 6 indexed citations
13.
Němeček, Radim, Lenka Radová, Tomáš Kazda, et al.. (2016). Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Škarda, Jozef, et al.. (2016). Prognostic significance of miR-23b in combination with P-gp, MRP and LRP/MVP expression in non-small cell lung cancer. Neoplasma. 63(4). 576–587. 18 indexed citations
15.
Němeček, Radim, Lenka Radová, Tomáš Kazda, et al.. (2016). Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. OncoTargets and Therapy. Volume 9. 4695–4703. 15 indexed citations
16.
Tichý, M, Zuzana Kubová, Tomáš Papajík, et al.. (2014). Diffuse large B-cell lymphoma: The history, current view and new perspectives. Neoplasma. 62(5). 491–504. 8 indexed citations
17.
Vrána, David, Jiří Gatěk, Pavel Koranda, et al.. (2014). Predictive parameters for internal mammary node drainage in patients with early breast cancer.. PubMed. 100(3). 254–8. 7 indexed citations
18.
Halada, Petr, Lenka Radová, Petr Džubák, et al.. (2012). Cancer Cell Response to Anthracyclines Effects: Mysteries of the Hidden Proteins Associated with These Drugs. International Journal of Molecular Sciences. 13(12). 15536–15564. 10 indexed citations
19.
Pastucha, Dalibor, et al.. (2012). Effect of Yoga Exercise on Metabolic and Homeostatic Parameters of Insulin Resistance. SHILAP Revista de lepidopterología. 12(1). 2 indexed citations
20.
Fabián, Pavel, Lenka Radová, Ondřej Slabý, et al.. (2012). Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. International Journal of Oncology. 41(4). 1204–1212. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rakesh Singal Breakdown of academic impact, for papers by Yong Xu Breakdown of academic impact, for papers by Christos K. Kontos Breakdown of academic impact, for papers by Sohye Kang Breakdown of academic impact, for papers by Cátia Moutinho Breakdown of academic impact, for papers by Adriana Aguilar‐Mahecha Breakdown of academic impact, for papers by Carl E. Freter Breakdown of academic impact, for papers by Catherine Lofton–Day Breakdown of academic impact, for papers by Carmen S. Tellez Breakdown of academic impact, for papers by Jer-Yen Yang
Rankless by CCL
2026